Evidence map›Paper›PMID 28493882›Full record

ArticlePloS one2017

Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.

Shabnam Alam, Cory Chan, Xing Qiu, Ian Shannon, Chantelle L White, Andrea J Sant, Jennifer L Nayak

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Immunity to Influenza Infection in Humans.Cold Spring Harbor perspectives in medicine · 2021
    Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shabnam AlamDepartment of Pediatrics, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, New York, United States of America.
Cory ChanDepartment of Pediatrics, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, New York, United States of America.
Xing QiuDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, United States of America.
Ian ShannonDepartment of Pediatrics, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, New York, United States of America.
Chantelle L WhiteDepartment of Pediatrics, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, New York, United States of America.
Andrea J SantDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America.
Jennifer L NayakDepartment of Pediatrics, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, New York, United States of America.ORCID http://orcid.org/0000-0002-5042-3031
University of Rochester Medical Center · US

Funding

Selective priming of HA-specific CD4 T cells in influenza heterosubtypic immunityK08AI106954 · NIAID · UNIVERSITY OF ROCHESTER · PI NAYAK, JENNIFER L. · 2013 to 2016
$677k
NIAID NIH HHS K08 AI106954
6 · The paper itself

Abstract

A hallmark of the immune response to influenza is repeated encounters with proteins containing both genetically conserved and variable components. Therefore, the B and T cell repertoire is continually being remodeled, with competition between memory and naïve lymphocytes. Our previous work using a mouse model of secondary heterosubtypic influenza infection has shown that this competition results in a focusing of CD4 T cell response specificity towards internal virion proteins with a selective decrease in CD4 T cell reactivity to the novel HA epitopes. Strikingly, this shift in CD4 T cell specificity was associated with a diminished anti-HA antibody response. Here, we sought to determine whether the loss in HA-specific reactivity that occurs as a consequence of immunological memory could be reversed by selectively priming HA-specific CD4 T cells prior to secondary infection. Using a peptide-based priming strategy, we found that selective expansion of the anti-HA CD4 T cell memory repertoire enhanced HA-specific antibody production upon heterosubtypic infection. These results suggest that the potentially deleterious consequences of repeated exposure to conserved influenza internal virion proteins could be reversed by vaccination strategies that selectively arm the HA-specific CD4 T cell compartment. This could be a potentially useful pre-pandemic vaccination strategy to promote accelerated neutralizing antibody production on challenge with a pandemic influenza strain that contains few conserved HA epitopes.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralCD4-Positive T-LymphocytesEpitopesHemagglutinins, ViralHumansImmunologic MemoryInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesMicePandemicsVaccinationAntibodies, NeutralizingAntibodies, ViralEpitopesHemagglutinins, ViralInfluenza Vaccines

Identifiers

PMID28493882
PMCPMC5426616
OpenAlexW2612426754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.